Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 7Phase 3 5Phase 2/3 4Phase 1/2 3Phase NA 1

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 16Colorectal Neoplasms 8Stomach Neoplasms 6Carcinoma, Hepatocellular 5Pancreatic Neoplasms 4Neoplasm Metastasis 4Biliary Tract Neoplasms 4Rectal Neoplasms 3Neoplasms 3Esophageal Neoplasms 3Colonic Neoplasms 3Esophageal Squamous Cell Carcinoma 2Adenocarcinoma Of Esophagus 2Triple Negative Breast Neoplasms 1Resected Liver Metastases From Colorectal Cancer 1Recurrence 1Quality of Life 1Oesophagogastric Cancer 1Malignant Tumor of Pancreas Metastatic to Liver 1Inflammatory Breast Neoplasms 1HER2-positive Gastric Cancer 1HER2-positive Breast Cancer 1Gastroesophageal Junction Adenocarcinoma 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Breast Diseases 1Bile Duct Neoplasms 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Gemcitabine 4Cisplatin 4Capecitabine 4Oxaliplatin 3Leucovorin 2Fluorouracil 2Albumin-Bound Paclitaxel 2titanium silicide 1tegafur-gimeracil-oteracil 1surufatinib 1pembrolizumab 1mitazalimab 1durvalumab 1cediranib 1anlotinib 1Taxes 1S 1 (combination) 1Paclitaxel 1Folfox protocol 1Control Groups 1ARRY-334543 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Biliary Tract Neoplasms × Capecitabine × Clear all
NCT05065957 2025-04-30

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

InnoPharmax Inc.

Phase 2/3 Recruiting
180 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT06037980 2025-02-17

PURITY

Gruppo Oncologico del Nord-Ovest

Phase 2/3 Recruiting
300 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT03093870 2021-08-03

TreeTopp

ASLAN Pharmaceuticals

Phase 2/3 Completed
151 enrolled 18 charts
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms

NCT03873532 2020-02-13

A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

Hutchmed

Phase 2/3 Unknown
298 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡